Wird geladen...
The combination of fluticasone furoate and vilanterol trifenatate in the management of asthma: clinical trial evidence and experience
The treatment of persistent asthma has been aided by the recent approval of new medications. The combined inhaled corticosteroid (ICS)/long-acting β2 agonist (LABA) powder inhaler fluticasone furoate (FF)/vilanterol trifenatate (VI) is one of these new agents, which was recently approved as a mainte...
Gespeichert in:
| Veröffentlicht in: | Ther Adv Respir Dis |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publications
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5933662/ https://ncbi.nlm.nih.gov/pubmed/26668137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753465815619136 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|